丹麦成人癌症幸存者远期躯体疾病风险
该全国性人群队列研究纳入458646例12种最常见首发原发癌症的成人幸存者和2121567名匹配的无癌对照,分析经医院确诊的躯体疾病住院风险。结果显示几乎所有诊断组中癌症幸存者的躯体疾病住院风险均显著高于无癌对照,提示随访中应密切监测新发躯体疾病。
要点
- 癌症幸存者诊断或入组时合并症比例高于无癌对照(Charlson合并症指数≥1:19% vs 13%)。
- 乳腺癌幸存者神经系统疾病住院风险升高(HR 1.20,95%CI 1.17-1.22)。
- 肺癌幸存者呼吸系统疾病住院风险升高(HR 5.85,95%CI 5.63-6.07)。
核心结论
- 研究结果提示,12种最常见癌症的成人幸存者因广谱躯体疾病住院的风险显著高于匹配的无癌对照。
- 研究结果提示在癌症幸存者随访照护中密切、有针对性地监测新发躯体疾病具有重要意义。
研究设计与样本
- 全国性、基于人群的队列-队列研究,纳入1997年1月1日至2014年12月31日丹麦癌症登记处登记的12种最常见首发原发癌症幸存者458646例及丹麦中央人口登记处匹配的无癌对照2121567人。
- 从全国患者登记处识别癌症诊断或研究入组后躯体疾病住院,按国际疾病分类第十版11个主要诊断组分层。
- 按每种癌症类型与诊断组组合形成幸存者队列及对应无癌人群,共132个独特队列;数据分析于2017年9月1日至2018年1月15日进行。
- 采用Cox比例风险回归模型分析住院风险及发病时间模式,采用伪观察法计算累积发病比例。
主要发现
- 共调查2580213人,其中癌症幸存者458646例(平均[SD]年龄69[11.6]岁;男性230793例[50.3%],女性227853例[49.7%]),无癌对照2121567人(平均[SD]年龄69[11.5]岁;男性1054465例[49.7%],女性1067102例[50.3%])。
- 癌症幸存者诊断或入组时合并症比例高于无癌对照(Charlson合并症指数≥1:19% vs 13%)。
- 总体而言,几乎所有诊断组中癌症幸存者的躯体疾病住院风险均显著更高。
- 乳腺癌幸存者神经系统疾病住院风险升高(HR 1.20,95%CI 1.17-1.22)。
- 肺癌幸存者呼吸系统疾病住院风险升高(HR 5.85,95%CI 5.63-6.07);前列腺癌幸存者血液及造血器官疾病住院风险升高(HR 2.60,95%CI 2.50-2.71)。
临床怎么用
- 原文结论提示在癌症幸存者随访照护中密切、有针对性地监测新发躯体疾病具有重要意义。
- 原文未据此给出具体监测方案或干预推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Long-term health effects of cancer in adult survivors are a major concern; however, it is difficult to differentiate between the consequences of cancer and cancer treatment and those of normal aging or comorbidity. OBJECTIVES: To provide an overview and investigate the temporal pattern of hospitalizations for medically verified incident somatic disease in adult survivors compared with cancer-free comparison people, taking into consideration pretreatment comorbidity and the socioeconomic position of the participants. DESIGN, SETTING, AND PARTICIPANTS: In this nationwide, population-based cohort-cohort study, 458 646 survivors of the 12 most frequent first primary cancers listed in the Danish Cancer Registry between January 1, 1997, and December 31, 2014, and 2 121 567 matched cancer-free comparison people were identified from the Danish Central Population Registry. Hospitalizations for somatic diseases after cancer diagnosis or study entry were identified from the National Patient Register and stratified according to the 11 main diagnostic groups in the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. A cohort of cancer survivors was formed for each combination of cancer type and diagnostic group, with a corresponding group of cancer-free people, resulting in 132 unique cohorts. Data analysis was performed from September 1, 2017, to January 15, 2018. MAIN OUTCOMES AND MEASURES: Risk of hospitalization and the temporal pattern of incidence were analyzed in Cox proportional hazards regression models. Cumulative incidence proportions were calculated by the pseudo-observation method. RESULTS: A total of 2 580 213 people were investigated, of whom 458 646 were cancer survivors (mean [SD] age, 69 [11.6] years; 230 793 [50.3%] male and 227 853 [49.7%] female) and 2 121 567 were comparison people (mean [SD] age, 69 [11.5] years; 1 054 465 [49.7%] male and 1 067 102 [50.3%] female). More cancer survivors vs comparison people had comorbid conditions at the time of cancer diagnosis or study entry (Charlson Comorbidity Index ≥1: 19% vs 13%). Overall, the risk of hospitalizations for somatic diseases was significantly higher for cancer survivors in almost all diagnostic groups (eg, diseases in the nervous system among breast cancer survivors: hazard ratio, 1.20; 95% CI, 1.17-1.22; diseases in the respiratory system in lung cancer survivors: hazard ratio, 5.85; 95% CI, 5.63-6.07; and diseases in blood and blood-forming organs in prostate cancer survivors: hazard ratio, 2.60; 95% CI, 2.50-2.71). CONCLUSIONS AND RELEVANCE: The findings suggest that adult survivors of the 12 most common cancers are at significantly higher risk for a broad range of somatic diseases that require hospitalization compared with matched cancer-free comparison people. The results of this study suggest the importance of close, targeted monitoring for new somatic disease during follow-up care of cancer survivors.
引用
- Kjaer TK, Andersen EAW, Winther JF, et al. Long-term Somatic Disease Risk in Adult Danish Cancer Survivors. JAMA Oncol. 2019. PMID: 30844031. doi:10.1001/jamaoncol.2018.7192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。